Zacks: Edap Tms S.A. (EDAP) Receives Consensus Rating of “Strong Buy” from Analysts

Shares of Edap Tms S.A. (NASDAQ:EDAP) have been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Brokers have set a 1 year consensus price target of $6.50 for the company and are expecting that the company will post ($0.01) EPS for the current quarter, according to Zacks. Zacks has also given Edap Tms an industry rank of 172 out of 265 based on the ratings given to its competitors.

EDAP has been the topic of a number of research reports. HC Wainwright reaffirmed a “buy” rating and issued a $6.50 price target on shares of Edap Tms in a research note on Friday, August 25th. Zacks Investment Research lowered shares of Edap Tms from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 29th. Finally, ValuEngine lowered shares of Edap Tms from a “hold” rating to a “sell” rating in a research note on Friday, September 1st.

Edap Tms (EDAP) traded up $0.01 during trading hours on Monday, hitting $3.10. The stock had a trading volume of 43,200 shares, compared to its average volume of 73,780. Edap Tms has a 52-week low of $2.25 and a 52-week high of $3.85. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.96 and a quick ratio of 2.35. The firm has a market cap of $90.50, a PE ratio of 103.33 and a beta of 1.05.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, November 15th. The medical equipment provider reported ($0.02) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.02). The firm had revenue of $8.44 million for the quarter, compared to analysts’ expectations of $11.05 million. Edap Tms had a positive return on equity of 5.89% and a negative net margin of 5.36%. The firm’s revenue for the quarter was down 5.6% compared to the same quarter last year. equities research analysts expect that Edap Tms will post -0.04 earnings per share for the current year.

A number of institutional investors have recently modified their holdings of the stock. Archon Capital Management LLC lifted its stake in Edap Tms by 12.5% in the 3rd quarter. Archon Capital Management LLC now owns 843,489 shares of the medical equipment provider’s stock valued at $2,514,000 after buying an additional 93,762 shares in the last quarter. Essex Investment Management Co. LLC lifted its stake in Edap Tms by 520.2% in the 3rd quarter. Essex Investment Management Co. LLC now owns 323,528 shares of the medical equipment provider’s stock valued at $964,000 after buying an additional 271,367 shares in the last quarter. Hilton Capital Management LLC lifted its stake in Edap Tms by 43.1% in the 2nd quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after buying an additional 25,000 shares in the last quarter. Finally, Virtu KCG Holdings LLC purchased a new position in Edap Tms in the 2nd quarter valued at about $117,000. 10.50% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Zacks: Edap Tms S.A. (EDAP) Receives Consensus Rating of “Strong Buy” from Analysts” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://ledgergazette.com/2017/12/06/zacks-edap-tms-s-a-edap-receives-consensus-rating-of-strong-buy-from-analysts.html.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Get a free copy of the Zacks research report on Edap Tms (EDAP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply